Year: 2018
Type: article
Abstract: Are small molecules or biologics the drugs of the future? Small-molecule drugs have historically been the pillars of traditional medicine. However, recently, we seem to be amidst a scientific revolution with the rise of many FDA-approved biologic drugs. This opinion article looks at the current state of small molecules and biologics and assesses what the future holds for these two broad classes of drugs.
Source: MedChemComm
DOI: 10.1039/c8md90019a
Authors: Huy X. Ngo, Sylvie Garneau-Tsodikova
Institution: University of Kentucky
Language: English
Subfield: Economics and Econometrics
Domain: Social Sciences
Open Access status: bronze
OpenAlex ID: W2802060229